<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Molecular pathology and pathogenesis of inclusion-body myositis</title>
			</titleStmt>
			<publicationStmt>
				<publisher>Wiley</publisher>
				<availability status="unknown"><p>Copyright Wiley</p>
				</availability>
				<date type="published" when="2005">2005</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><roleName>Dr</roleName><forename type="first">Valerie</forename><surname>Askanas</surname></persName>
							<email>askanas@usc.edu</email>
						</author>
						<author>
							<persName><forename type="first">W</forename><forename type="middle">King</forename><surname>Engel</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution" key="instit1">USC Neuromuscular Center</orgName>
								<orgName type="institution" key="instit2">University of Southern California Keck School of Medicine</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="institution">Good Samaritan Hospital</orgName>
								<address>
									<postCode>90017-1912</postCode>
									<settlement>Los Angeles</settlement>
									<region>California</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="institution" key="instit1">USC Neuromuscular Center</orgName>
								<orgName type="institution" key="instit2">Good Samaritan Hospital</orgName>
								<address>
									<addrLine>637 S. Lucas Ave</addrLine>
									<postCode>90017-1912</postCode>
									<settlement>Los Angeles</settlement>
									<region>CA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="institution">by University Of Illinois At Urbana Champaign</orgName>
								<address>
									<addrLine>Wiley Online Library on [05</addrLine>
									<country>03</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Molecular pathology and pathogenesis of inclusion-body myositis</title>
					</analytic>
					<monogr>
						<title level="j" type="main">Microscopy Research and Technique</title>
						<title level="j" type="abbrev">Microsc. Res. Tech.</title>
						<idno type="ISSN">1059-910X</idno>
						<idno type="eISSN">1097-0029</idno>
						<imprint>
							<publisher>Wiley</publisher>
							<biblScope unit="volume">67</biblScope>
							<biblScope unit="issue">3-4</biblScope>
							<biblScope unit="page" from="114" to="120"/>
							<date type="published" when="2005" />
						</imprint>
					</monogr>
					<idno type="MD5">28B1A37024278B37C68ADC786F34CB0E</idno>
					<idno type="DOI">10.1002/jemt.20186</idno>
					<note type="submission">Received 17 March 2005; accepted in revised form 12 April 2005</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2" ident="GROBID" when="2023-03-30T18:12+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>We summarize the molecular phenotype, diagnostic criteria, and the newest advances related to seeking the pathogenic mechanism(s) of sporadic inclusion-body myositis (s-IBM), a muscle disease usually of persons over age 50. On the basis of our research, several processes seem to be important in relation to the still-speculative pathogenesis: 1) increased transcription and accumulation of amyloid-b precursor protein (AbPP), and accumulation of its proteolytic fragment Ab; 2) abnormal accumulation of cholesterol, caveolin-1, and apolipoprotein E; 3) oxidative stress; 4) accumulations of intramuscle fiber multiprotein aggregates; and 5) evidence that unfolded/misfolded proteins participate in s-IBM pathogenesis. Our basic hypothesis is that overexpression of AbPP within the aging muscle fibers is an early upstream event causing a subsequent pathogenic cascade.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p>The term ''inclusion-body myositis'' (IBM) designated a subset of patients with chronic polymyositis whose muscle biopsies have, in addition to inflammation, muscle fibers containing 1) vacuoles, and 2) characteristic filamentous inclusions within the cytoplasm and nuclei. Sporadic IBM (s-IBM) is the most common muscle disease beginning after age 50, which leads to severe disability (reviewed by <ref type="bibr" target="#b4">Askanas and Engel, 2001</ref><ref type="bibr">, 2002</ref><ref type="bibr">, 2003)</ref>. Interest in s-IBM has been increased by a) the recent identification within IBM muscle fibers of b-pleated-sheet amyloid <ref type="bibr" target="#b40">(Mendell et al., 1991;</ref><ref type="bibr" target="#b7">Askanas et al., 1992a)</ref> and other striking pathologic features that were not believed to occur in diseased human muscle, and b) the remarkable parallels of those features with ones typically present in Alzheimer's disease (AD) brain (reviewed by <ref type="bibr" target="#b4">Askanas and Engel, 2001)</ref>. For example, the most characteristic feature of the s-IBM muscle-fiber pathologic phenotype is accumulation of intramuscle-fiber multiprotein aggregates containing either amyloid-b (Ab) or phosphorylated tau (p-tau) <ref type="bibr" target="#b4">(Askanas and Engel, 2001)</ref>. Both types of aggregates contain ubiquitin and several other accumulated proteins <ref type="bibr" target="#b4">(Askanas and Engel, 2001</ref><ref type="bibr">, 2002</ref><ref type="bibr">, 2003)</ref>, including markers of oxidative stress <ref type="bibr" target="#b59">(Yang et al., 1996)</ref> and cholesterol <ref type="bibr">(Jaworska-Wilczynska et al., 2002)</ref>. Their possible pathogenetic significance is addressed below.</p><p>Traditionally, s-IBM has been considered an inflammatory myopathy, together with polymyositis and dermatomyositis, and several reviews have addressed the inflammatory aspects of those disorders <ref type="bibr">(Dalakas, 2001;</ref><ref type="bibr" target="#b27">Hilton-Jones, 2001;</ref><ref type="bibr" target="#b37">Mastaglia et al., 2003)</ref>. However, while the inflammatory component of s-IBM muscle biopsies is indisputable, its pathogenic significance is uncertain because s-IBM patients as a group respond poorly to anti-dysimmune treatment, in contrast to polymyositis and dermatomyositis patients <ref type="bibr" target="#b4">(Askanas and Engel, 2001;</ref><ref type="bibr" target="#b27">Hilton-Jones, 2001;</ref><ref type="bibr" target="#b37">Mastaglia et al., 2003)</ref>.</p><p>In s-IBM we have proposed that the milieu of the aging muscle fiber is important in promoting: 1) development of the IBM-characteristic progressive vacuolar degeneration; and 2) the characteristic ectopic expression of several potentially toxic proteins, which may underlie disease progression. The aging milieu of the s-IBM musclefiber and of total-patient may also influence provocation of, and/or response to, the lymphocytic inflammation (reviewed by <ref type="bibr">Askanas and</ref><ref type="bibr" target="#b39">Engel, 2002, 2003)</ref>.</p><p>Accordingly, we postulate that s-IBM is essentially a degenerative muscle disease 1) occurring in an aged muscle cellular environment; 2) associated with intracellular accumulation and aggregation of several proteins; and 3) involving abnormal signal transduction and transcription, all of which lead to the IBM-specific characteristic muscle degenerative process.</p><p>In this review we describe what seem to be the most important molecular aspects of the s-IBM muscle fiber phenotype and our newest considerations of s-IBM pathogenesis.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MORPHOLOGIC DIAGNOSTIC CRITERIA</head><p>OF S-IBM Light-Microscopic Histochemistry and Immunocytochemistry Characteristic light-microscopic pathologic features of s-IBM evident with the Engel-Gomori trichrome stain <ref type="bibr" target="#b19">(Engel and Cunningham, 1963)</ref> are: 1) muscle fibers with one or several, irregular and various-sized, vacuoles on a given 10-mm thick fresh-frozen cross-section, and 2) various degrees of lymphocytic inflammation, with some macrophages (Fig. <ref type="figure" target="#fig_0">1</ref>). In contrast to what is commonly stated, many vacuoles in IBM are either not ''rimmed'' or only slightly rimmed. In a given section, 60-80% of the s-IBM vacuolated muscle fibers contain amyloid foci positive with Congo-red, thioflavin-s, and crystal violet. Because amyloid deposits can be very small and sometimes present in only a few muscle fibers, they can often be missed if examined only by Congo-red visualized through polarizing filters, thioflavin-s, or crystal violet. The fluorescenceenhanced Congo-red technique described previously greatly facilitates identification of amyloid deposits <ref type="bibr" target="#b9">(Askanas et al., 1993a)</ref>. We recommend the following morphologic criteria to diagnose s-IBM:</p><p>1. Engel-Gomori trichrome staining to visualize vacuolated muscle fibers, mononuclear-cell inflammation, and the occasional ragged-red fibers. 2. The Askanas fluorescence-enhanced Congo-red staining to visualize intramuscle fiber congophilia. 3. Immunocytochemical staining for the presence of paired-helical filaments (PHFs) utilizing SMI-31 monoclonal antibody, which recognizes the phosphorylated tau of PHFs in s-IBM <ref type="bibr" target="#b11">(Askanas et al., 1996a;</ref><ref type="bibr" target="#b41">Mirabella et al., 1996a)</ref> and AD <ref type="bibr" target="#b34">(Ksiezak-Reding et al., 1987)</ref> (although originally made to react with the phosphorylated heavy-chain of neurofilaments). 4. Ubiquitin immunoreactivity within muscle fibers can be used to differentiate s-IBM from polymyositis if SMI-31 antibody is not available <ref type="bibr" target="#b8">(Askanas et al., 1992b)</ref>. Ubiquitin-positive inclusions can be identified in both fresh-frozen and formalin-fixed paraffinembedded muscle biopsies of s-IBM patients, but not in any other inflammatory myopathies <ref type="bibr" target="#b8">(Askanas et al., 1992b;</ref><ref type="bibr" target="#b44">Prayson and Cohen, 1997)</ref>.</p><p>Ultrastructural Abnormalities of s-IBM Vacuolated, and Some Nonvacuolated, Muscle Fibers Characteristic are PHFs, often in clusters, strikingly resembling PHFs of AD brain, being 15-21 nm in diameter and containing phosphorylated tau (Fig. <ref type="figure" target="#fig_1">2</ref>) (reviewed by <ref type="bibr" target="#b4">Askanas and Engel, 2001)</ref>. PHFs are present in both vacuolated and nonvacuolated muscle fibers. In 2-6% of s-IBM muscle nuclei there are clusters (inclusions) of 15-21 nm ''tubulofilaments,'' which in favorable sections are seen to be paired-helical filaments like those in the cytoplasm.</p><p>The s-IBM vacuolated muscle-fiber cytoplasm, and often cytoplasm of the nonvacuolated muscle fibers, also contain Ab-positive: 1) collections of 6-10 nm fila- ments (Fig. <ref type="figure" target="#fig_1">2</ref>); 2) fine flocculomembranous material; and 3) amorphous material <ref type="bibr" target="#b8">(Askanas et al., 1992b</ref><ref type="bibr" target="#b10">(Askanas et al., , 1993b))</ref>. Myelin-like whorls and other lysosomal debris are present in the vacuolated fibers. Ultrastructurally abnormal mitochondria containing paracrystalline inclusions are occasionally present.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>EVIDENCE FOR INTRACELLULAR TOXICITY</head><p>OF AbPP/Ab IBM PATHOGENESIS We have proposed that increased intracellular expression and accumulation of amyloid-b precursor protein (AbPP) and Ab, and possibly Ab oligomers, play a key upstream role in the s-IBM pathogenesis by: 1) causing abnormal signal transduction to modulating other genes; 2) binding to and adversely modifying the role of various normal intracellular proteins; 3) trapping potentially other toxic proteins and cholesterol; 4) inducing oxidative stress; and 5) producing mitochondrial and other abnormalities (reviewed by <ref type="bibr">Askanas and</ref><ref type="bibr" target="#b39">Engel, 2002, 2003)</ref>. (The recent concept of a putative toxicity of small proteolytic fragments of Ab in AD <ref type="bibr" target="#b33">[Klein, 2002]</ref> could also apply intracellularly to IBM.) This proposal is supported by studies showing that: a) experimental overexpression of AbPP through direct AbPP gene transfer into human normal, cultured muscle fibers induced most of the basic aspects of the IBM phenotype <ref type="bibr" target="#b42">(Askanas et al., 1996b</ref><ref type="bibr" target="#b14">(Askanas et al., , 1997))</ref>; b) in hereditary-IBM cultured muscle fibers, the genetically determined AbPP overexpression preceded other IBMlike abnormalities <ref type="bibr" target="#b39">(McFerrin et al., 2000)</ref>; and c) both experimentally and genetically AbPP-overexpressing cultured muscle fibers had abnormal neuromuscular junctions (NMJs) and could not become innervated by cocultured fetal-rat spinal-cord neurons <ref type="bibr" target="#b38">(McFerrin et al., 1998)</ref>. Based on the last finding and our IBM muscle-biopsy observation <ref type="bibr" target="#b1">(Alvarez et al., 2000)</ref>, we postulated that spontaneous AbPP overexpression in s-IBM patient muscle fibers may be responsible for a ''myogenous dysinnervation'' <ref type="bibr" target="#b4">(Askanas and al., 2001)</ref> and for the observed NMJ structural abnormalities <ref type="bibr" target="#b1">(Alvarez et al., 2000)</ref>. The neuromuscular synapse pathology in IBM has a parallel in the synapse pathology of AD <ref type="bibr" target="#b50">(Terry, 1996)</ref> which, by analogy with IBM, we propose may reflect an intracellular postsynaptic pathogenic mechanism.</p><p>Additional support of our intracellular AbPP/Ab hypothesis of IBM pathogenesis was provided by transgenic mouse models overexpressing AbPP in muscle fibers <ref type="bibr" target="#b29">(Jin et al., 1998;</ref><ref type="bibr" target="#b25">Fukuchi et al., 1998)</ref>. Based on the likely intracellular toxicity of AbPP/Ab in s-IBM muscle fibers, we have suggested that a similar intracellular may be occurring in AD neurons and possibly astroglia <ref type="bibr">(Askanas and Engel, 1998a)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INCREASED TRANSCRIPTION OF AbPP</head><p>AND ITS ABNORMAL PROCESSING WITHIN S-IBM MUSCLE FIBERS Ab and C-and N-terminal epitopes of AbPP are abnormally accumulated in vacuolated and nonvacuolated regions of s-IBM muscle fibers <ref type="bibr" target="#b8">(Askanas et al., 1992b</ref><ref type="bibr" target="#b10">(Askanas et al., , 1993b))</ref>. s-IBM muscle fibers have increased mRNA signal for the AbPP-751 alternatively spliced transcript that contains the Kunitz-type protease inhibitor (KPI) motif <ref type="bibr">(Sarkozi et al., 1993)</ref>. The increased AbPP-mRNA colocalizes in the same foci as the abnormal accumulations of AbPP and Ab immunoreactive epitopes <ref type="bibr">(Sarkozi et al., 1993)</ref>. The mechanism of AbPP overproduction in s-IBM is not clarified, but our recent studies suggest that the AP-1 transcription complex, composed of c-Jun and c-Fos, may play a role (reviewed and referenced in <ref type="bibr" target="#b4">Askanas and Engel, 2001)</ref>.</p><p>Jun/Ap-1 and protein kinase C have been shown to play a role in AbPP transcription <ref type="bibr" target="#b50">(Trejo et al., 1994)</ref>. Since c-Jun, c-Fos <ref type="bibr" target="#b18">(Broccolini et al., 2000b)</ref>, ERK <ref type="bibr" target="#b28">(Wilczynski et al., 2000)</ref>, and PKC <ref type="bibr">(Askanas et al., unpubl. data)</ref> are increased in IBM muscle fibers, they may play a role in the AbPP overexpression.</p><p>Also increased in IBM muscle is Redox-factor-1 (Ref-1) <ref type="bibr" target="#b18">(Broccolini et al., 2000a)</ref>, a protein possessing apurinic/apyrimidic endonuclease activity, as well as the ability to increase the affinity of AP1 for its binding site in the promoter region of several target genes including AbPP, thereby modulating their transcription. Ref-1 also enhances binding of the transcription factor nuclear factor-kB (NFkB) to DNA, thus participating in the increased transcription of several genes, including AbPP. Oxidative stress induces Ref-1 activation. IBM muscle fibers contain increased NFkB <ref type="bibr" target="#b60">(Yang et al., 1998)</ref> and markers of oxidative stress <ref type="bibr" target="#b59">(Yang et al., 1996)</ref>, which might also be involved in the increased AbPP transcription. RNA polymerase II is also increased in IBM fibers <ref type="bibr" target="#b58">(Wilczynski et al., 2001)</ref>, another sign suggesting increased transcription activity.</p><p>Recently, we have demonstrated that the machinery for abnormal processing of AbPP, leading to the increased generation of the toxic Ab42 fragment, exists in s-IBM muscle fibers. Those include the following: 1) BACE1 and BACE2, glycosylated transmembrane proteins, which are recently discovered b-secretases that cleave AbPP at the N-terminal of Ab <ref type="bibr" target="#b48">(Sinha et al., 1999;</ref><ref type="bibr" target="#b0">Acquati et al., 2000;</ref><ref type="bibr" target="#b28">Hussain et al., 2000)</ref>. BACE1 and BACE2 are increased in s-IBM muscle fibers, where they are accumulated in the form of inclusions colocalizing with Ab <ref type="bibr" target="#b53">(Vattemi et al., 2001</ref><ref type="bibr">(Vattemi et al., , 2003a))</ref>. In addition, both BACEs coimmunoprecipitate with AbPP in s-IBM muscle, providing novel evidence that they may participate in AbPP processing and abnormal generation of Ab there. 2) Nicastrin and presenilins (PSs), which are components of the g-secretase system that cleaves AbPP at the C-terminal of Ab, generating either Ab40 or Ab42 <ref type="bibr">(Sisodia et al., 2001)</ref>. Nicastrin, PS1, and PS2 are strongly overexpressed in s-IBM muscle fibers, where they i) colocalize with each other and with Ab <ref type="bibr" target="#b15">(Askanas et al., 1998;</ref><ref type="bibr" target="#b55">Vattemi et al., 2003b)</ref>, and ii) are physically associated with AbPP in s-IBM and AbPP-overexpressing muscle fibers (Vattemi and <ref type="bibr">Askanas, unpubl. obs., 2003)</ref>, strongly suggesting that those factors participate in the Ab production within IBM muscle fibers. 3) Abnormally accumulated free cholesterol and apolipoprotein E (See below). 4) CystatinC (CC), an endogenous cysteine protease inhibitor, which was previously proposed to participate in Ab deposition within the amyloid plaques AD brain <ref type="bibr" target="#b19">(Deng et al., 2001;</ref><ref type="bibr" target="#b35">Levy et al., 2001</ref>). Within biopsied s-IBM muscle fibers, CC is strongly immunoreactive in the form of inclusions that ultrastructurally colocalize with the Ab immunoreactivity; CC's total expression is strongly increased, and it coimmunoprecipitated with AbPP <ref type="bibr" target="#b55">(Vattemi et al., 2003c)</ref>. Our studies demonstrate for the first time that CC physically associates with AbPP, suggesting that it possibly influences ABPP processing as well as Ab deposition.</p><p>Accordingly, the mechanisms participating both in the increased transcription of AbPP and its abnormal processing seem to be overoperating within s-IBM muscle fibers.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CHOLESTEROL AND RELATED MECHANISMS IN THE IBM PATHOGENESIS</head><p>Free cholesterol is abnormally accumulated in IBM muscle fibers <ref type="bibr">(Jaworska-Wilczynska et al., 2002)</ref>. It colocalizes with abnormally accumulated Ab, phosphorylated tau, and caveolin-1 (Jaworska- <ref type="bibr">Wilczynska et al., 2003;</ref><ref type="bibr">Keffi et al., 2002)</ref>. In addition to being abnormally accumulated within s-IBM muscle fibers, caveolin-1, a major protein of plasmalemmal microdomain caveolae and an intracellular transporter of cholesterol <ref type="bibr" target="#b20">(Fielding and Fielding, 2000)</ref>, is physically associated with AbPP in the s-IBM muscle fibers, suggesting its having a direct role in AbPP processing <ref type="bibr">(Vattemi and Askanas, unpubl. obs., 2003)</ref>. In nonmuscle-cells, experimental loading with cholesterol increases Ab production and amyloidogenesis <ref type="bibr">(referenced in Jaworsk-Wilczynska et al., 2002)</ref>, and in AbPP-overexpressing cultured human muscle fibers exposure to cholesterol induces Ab-deposition and overexpression of caveolin-1 <ref type="bibr" target="#b39">(McFerrin et al., 2002)</ref>. We therefore propose that within s-IBM muscle fibers cholesterol, instead of being properly metabolized or cleared, is deposited, with caveolin-1, at sites of Ab accumulation and possibly at sites of AbPP processing, where it might adversely increase Ab production and induce Ab misfolding and aggregation.</p><p>ApoE is abnormally accumulated within s-IBM muscle fibers <ref type="bibr" target="#b42">(Mirabella et al., 1996b)</ref>. Its light-microscopic localization is in the form of intracellular inclusions that closely colocalize with phosphorylated-tau and Ab. Ultrastructurally, it is localized to PHFs, 6-10 nm filaments, and amorphous material. Because ApoE-mRNA is not present in IBM abnormal muscle fibers <ref type="bibr" target="#b42">(Mirabella et al., 1996b)</ref>, we postulate that ApoE is transported from the circulation into those fibers through the low-density-lipoprotein receptors. In AD, <ref type="bibr" target="#b45">Rosenberg (2000)</ref> addressed the possible pathogenic role of neuronal lipoprotein-receptor-related protein (LRP), including its function in transporting ApoE, AbPP, cholesterol, and a-2 macroglobulin. In IBM muscle the roles of ApoE and its transport receptor need to be studied. Because ApoE binds to b-pleatedsheet amyloid produced by various proteins and to Ab (reviewed by <ref type="bibr" target="#b45">Rosenberg, 2000;</ref><ref type="bibr">Askanas and Engel, 1998a)</ref>, it is possible that after transport of ApoE into IBM abnormal muscle fibers it is captured by Ab and further enhances Ab fibrillogenesis. In sporadic and late-onset-familial forms of AD an increased frequency of the ApoE 4 allele is associated with earlier clinical onset (reviewed by <ref type="bibr" target="#b45">Rosenberg, 2000)</ref>. In s-IBM patients the ApoE 4 allele was not preferentially increased in two studies, but one group did report an increase (referenced in <ref type="bibr" target="#b3">Askanas and Engel, 1998b)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>OXIDATIVE STRESS HAS A POSSIBLE INFLUENCE IN THE PATHOGENIC CASCADE OF S-IBM</head><p>There is increasing evidence that free-radical toxicity may participate in the IBM pathogenesis. Indicators of oxidative stress, as well as enzymes participat-ing in the cellular defense against oxidative stress, are accumulated in IBM muscle fibers <ref type="bibr" target="#b59">(Yang et al., 1996</ref><ref type="bibr" target="#b60">(Yang et al., , 1998;;</ref><ref type="bibr" target="#b18">Broccolini et al., 2000a;</ref><ref type="bibr">reviewed by Askanas and</ref><ref type="bibr">Engel, 1998b, 2001)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>POSSIBLE MECHANISMS UNDERLYING FORMATION OF THE INCLUSION-BODIES</head><p>IN THE IBM MUSCLE FIBERS Diseases characterized by protein misfolding and aggregation are considered ''conformational diseases'' (reviewed by <ref type="bibr" target="#b26">Garcia-Mata et al., 2002;</ref><ref type="bibr" target="#b34">Kopito and Ron, 2000)</ref>. Aggregations of proteins into insoluble intracellular protein-complexes and inclusion-bodies have been proposed to be importantly related to several neurodegenerative disorders <ref type="bibr" target="#b39">(McNaught et al., 2003;</ref><ref type="bibr" target="#b32">Keller et al., 2000;</ref><ref type="bibr" target="#b46">Schmidt et al., 2002)</ref>. Some of the proteins accumulated in s-IBM muscle fibers within the inclusions/aggregates, such as a-synuclein, cellular prion protein, presenilin1, and SOD1 (reviewed in <ref type="bibr">Askanas and Engel, 20001, 2003)</ref> have, similar to Ab and tau, a propensity to unfold, misfold, and form b-pleated sheet amyloid <ref type="bibr" target="#b18">(Borden, 1998;</ref><ref type="bibr" target="#b36">Martin and Surewicz, 2001)</ref>. Accordingly, we postulate that formation of the IBMcharacteristic ubiquitinated multiprotein-inclusions in s-IBM muscle is due to protein unfolding and misfolding. Unfolding or misfolding of erstwhile normal proteins can occur in vivo and in vitro under several circumstances, including macromolecular crowding, oxidative stress, exposure to toxins and ''aging.'' Markers of oxidative stress are increased in muscle fibers of s-IBM, and there is increased transcription of several genes, viz., AbPP-751, cellular prion protein, enzymes involved in cellular defense against oxidative stress and c-Jun. Those factors might be contributing to increased transcription, impaired disposal (see below), and abnormal accumulation and crowding of proteins leading to their unfolding, possibly abnormal glycosylation, and other deleterious consequences to the proteins and the muscle cell function. The actual mechanisms preceding and leading to the formation of the inclusion-bodies in s-IBM muscle are now gradually being veiled.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Endoplasmic Reticulum Stress</head><p>Various factors, including the presence of misfolded proteins, oxidative stress, and abnormally glycosylated proteins, can interfere with endoplasmic reticulum (ER) function leading to ER stress (ERS) (reviewed by <ref type="bibr" target="#b43">Mori, 2000;</ref><ref type="bibr">Lee, 2001;</ref><ref type="bibr" target="#b31">Kaufman, 2002)</ref>. Unfolded protein response (UPR) is a mechanism by which cells attempt to protect themselves against ERS <ref type="bibr" target="#b31">(Kaufman, 2002)</ref>. It involves upregulation of several classes of ER chaperone proteins, whose main functions are to: 1) facilitate folding of the unfolded proteins, and 2) prevent protein aggregation. In s-IBM muscle fibers there are abnormal focal accumulations of five ER chaperones: BiP/GRP78, GRP94, Erp72, calreticulin, and calnexin, each of which colocalizes with Ab <ref type="bibr" target="#b56">(Vattemi et al., 2004)</ref>. Moreover, each of these five ER chaperones physically associates with AbPP/Ab in s-IBM muscle <ref type="bibr" target="#b56">(Vattemi et al., 2004)</ref>, suggesting that they may have a role in attempting to fold AbPP and/or Ab. Accordingly, the ERS and UPR in s-IBM muscle fibers strongly suggest that unfolded/misfolded proteins participate in the pathogenic cascade.</p><p>Transcription Errors; Accumulation of Mutated Ubiquitin (UBB +1 ) UBB þ1 is produced by an acquired transcriptional error, a ''molecular misreading,'' typically in an aging cellular environment. The aberrant transcripts are formed as a result of dinucleotide loss during or after transcription, and can be translated from the deletion onward into the þ1 reading frame <ref type="bibr" target="#b51">(van Leeuwen et al., 1998</ref><ref type="bibr" target="#b52">(van Leeuwen et al., , 2000))</ref>. UBB þ1 was recently shown to be accumulated in AD brain <ref type="bibr" target="#b51">(van Leeuwen et al., 1998</ref><ref type="bibr" target="#b52">(van Leeuwen et al., , 2000))</ref>. UBB þ1 is definitely accumulated in s-IBM muscle fibers, where it colocalizes with Ab and p-tau <ref type="bibr" target="#b22">(Fratta et al., 2004a)</ref>. Aging and oxidative stress are possible facilitators of UBB þ1 accumulation in AD brain, and they may be similarly facilatory in s-IBM muscle fibers. UBB þ1 is toxic to cells because its ubiquitinated form inhibits proteasome <ref type="bibr" target="#b36">(Lindsten et al., 2002)</ref> and there may be other toxic mechanisms.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Inhibition of Proteasome and</head><p>Aggresome Formation The ubiquitin-proteasome system (UPS) is the main protein degradation pathway in eukaryotic cells <ref type="bibr" target="#b57">(Voges et al., 1999;</ref><ref type="bibr">Ciechanover and Brundin, 2003)</ref>. It is involved in elimination of a variety of proteins, including short-lived-normal proteins and misfolded or otherwise damaged proteins. UPS inhibition leads to intracellular accumulation and aggregation of misfolded/ unfolded proteins <ref type="bibr" target="#b47">(Shoesmith et al., 2003;</ref><ref type="bibr" target="#b34">Kopito and Ron, 2000;</ref><ref type="bibr" target="#b17">Bennett et al., 2005)</ref>, and formation of organized structures termed aggresomes <ref type="bibr">(Johnson et al., 1998;</ref><ref type="bibr" target="#b57">Wigley, 1999;</ref><ref type="bibr" target="#b34">Kopito, 2000)</ref>. In addition to containing various misfolded proteins, aggresomes, characterized by their containing g-tubulin immunoreactivity, typically also contain ubiquitin, proteasome subunits, heat shock protein (Hsp)70, and other proteins. In s-IBM muscle fibers we have recently demonstrated proteasomal dysfunction, as evidenced by: 1) accumulation of subunits of the 26S proteasome; 2) decreased proteasomal activity; and 3) accumulation of aggresomes <ref type="bibr" target="#b21">(Fratta et al., 2003</ref><ref type="bibr" target="#b23">(Fratta et al., , 2004b;;</ref><ref type="bibr" target="#b24">Fratta et al., 2005)</ref>. Thus, proteasomal abnormalities may play an important role in the s-IBM pathogenesis. We propose that the unfolded/misfolded proteins might be responsible for cellular toxicity prior to their binding to each other and their final aggregation into inclusions bodies.</p><p>It is possible that after becoming aggregated, malfolded proteins have reduced, or perhaps no, cytotoxicity.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CONCLUSION</head><p>We have presented what we consider the most relevant findings related to the pathogenesis of s-IBM. These have not yet provided a definitive cause and treatment, but they have pointed to potentially exciting avenues for exploring treatment approaches to benefiting s-IBM patients. Examples are identification of factors that would: 1) decrease intramuscle fiber expressions of band g-secretases which might lead to decreased production of intracellularly toxic oligomeric Ab42; 2) detoxify free radicals or prevent their formation within muscle fibers; 3) prevent misfolding/unfolding of muscle-fiber proteins and/or enhance their disposal; and 4) decrease protein aggregation.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1 .</head><label>1</label><figDesc>Fig. 1. Light-microscopic features of s-IBM muscle biopsy. A,B: Engel Trichrome staining demonstrating vacuolated muscle fibers and mononuclear inflammation (A), and vacuolated and atrophic muscle fibers in (B). C,D: Congo-red staining visualized through Texas-red filters and epifluorescence illumination shows amyloid deposits within abnormal muscle fibers. E: Characteristic squiggly inclusions stained with SMI-31 antibody in abnormal muscle fibers. All Â1,250.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 2 .</head><label>2</label><figDesc>Fig. 2. Electron microscopic features of s-IBM muscle. A: Several paired helical filaments (PHFs) in transmission electron-microscopy. B,C: Clusters of PHFs stained with SMI-31 and processed for goldimmunoelectron-microscopy (B), and horseradish-immunoperoxidase (C), demonstrating that only PHFs are stained with SMI-31, whereas the adjacent portions of myofibers are not immunostained. D-F: Gold-immunoelectron-microscopy of Ab demonstrates its localization on 6-10 nm fibrils and floccular and amorphous material. A: Â80,000; B,D: Â53,000; C,E,F: Â46,000.</figDesc></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0">V. ASKANAS AND W.K. ENGEL 10970029, 2005, 3-4, Downloaded from https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/jemt.20186 by University Of Illinois At Urbana Champaign, Wiley Online Library on [05/03/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</note>
		</body>
		<back>

			<div type="funding">
<div xmlns="http://www.tei-c.org/ns/1.0"><p>National Institutes of Health; Contract grant number: AG16768 Merit Award (to VA); Grant sponsors: Muscular Dystrophy Association, Myositis Association, Helen Lewis Research Fund.</p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">The gene encoding DRAP (BACE2), a glucosylated transmembrane protein of the aspartic protease family, maps to the Down critical region</title>
		<author>
			<persName><forename type="first">F</forename><surname>Acquati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Accarino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Nucci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Fumagalli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Jovine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ottolenghi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Taramelli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEBS Lett</title>
		<imprint>
			<biblScope unit="volume">468</biblScope>
			<biblScope unit="page" from="59" to="64" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Ultrastructural abnormalities of neuromuscular junctions in sporadic inclusion-body myositis</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="240" to="241" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<imprint>
			<biblScope unit="volume">153</biblScope>
			<biblScope unit="page" from="1673" to="1677" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Sporadic inclusion-body myositis and its similarities to Alzheimer disease brain. Recent approaches to diagnosis and pathogenesis, and relation to aging</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scand J Rheumatol</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="389" to="405" />
			<date type="published" when="1998">1998b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Inclusion-body myositis: newest concepts of pathogenesis and relation to aging and Alzheimer disease</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neuropathol Exp Neurol</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="1" to="14" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Inclusion-body myositis and myopathies: different etiologies, possibly similar pathogenic mechanisms</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Neurol</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="525" to="531" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Proposed pathogenetic cascade of inclusion-body myositis: importance of amyloid-b, misfolded proteins, predisposing genes, and aging</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Rheumatol</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="737" to="744" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Light-and electronmicroscopic localization of b-amyloid protein in muscle biopsies of patients with inclusion-body myositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">141</biblScope>
			<biblScope unit="page" from="131" to="136" />
			<date type="published" when="1992">1992a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Immunocyto-chemical localization of ubiquitin in inclusion-body myositis allows its light-microscopic distinction from polymyositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Serdaroglu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="460" to="461" />
			<date type="published" when="1992">1992b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Enhanced detection of Congo-red positive amyloid deposits in muscle fibers of inclusionbody myositis and brain of Alzheimer disease using fluorescence technique</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="1265" to="1267" />
			<date type="published" when="1993">1993a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Beta-amyloid precursor epitopes in muscle fibers of inclusion-body myositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="551" to="560" />
			<date type="published" when="1993">1993b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Use of antineurofilament antibody to identify paired-helical filaments in inclusion-body myositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mirabella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="389" to="391" />
			<date type="published" when="1996">1996a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcferrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Baque</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sarkozi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="page" from="1314" to="1319" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">bAPP gene transfer into cultured human muscle induces inclusion-body myositis aspects</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcferrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Baque</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroreport</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="2155" to="2158" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Light and electron microscopic immunolocation of Presenilin 1 in abnormal muscle fibers of patients with sporadic inclusionbody myositis and autosomal-recessive inclusion-body myopathy</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C-C</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Vm-Y</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wisniewski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">152</biblScope>
			<biblScope unit="page" from="889" to="895" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Novel immunolocalization of a-synuclein in human muscle of inclusion-body myositis, regenerating and necrotic muscle fibers, and at neuromuscular junctions</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcferrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Broccolini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neuropathol Exp Neurol</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="592" to="598" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates preceded inclusion body formation</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Bennett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">F</forename><surname>Bence</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Jayakumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Kopito</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Cell</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="351" to="365" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Ciechanover A, Brundin P. 2003. The ubiquitin proteasome system in neurodegenerative diseases. Sometimes the chicken, sometimes the egg</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Borden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Broccolini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Broccolini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Pharmacol</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="300" to="306" />
			<date type="published" when="1998">1998. 2000a. 2000b. 2001</date>
			<publisher>Dalakas MC</publisher>
		</imprint>
	</monogr>
	<note>Neurosci Lett</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Rapid examination of muscle tissue and improved trichrome method for fresh-frozen biopsy sections</title>
		<author>
			<persName><forename type="first">A</forename><surname>Deng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Irizarry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Nitsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Growdon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Rebeck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Cunningham</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">159</biblScope>
			<biblScope unit="page" from="919" to="923" />
			<date type="published" when="1963">2001. 1963</date>
		</imprint>
	</monogr>
	<note>Neurology</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Cholesterol and caveolae: structural and functional relationships</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Fielding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Fielding</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem Biophys Acta</title>
		<imprint>
			<biblScope unit="volume">1529</biblScope>
			<biblScope unit="page" from="210" to="222" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Novel identification of aggresomes in sporadic inclusion-body myositis (s-IBM) muscle fibers suggests that inhibition of 26S/20S proteasome and misfolded proteins play a pathogenic role</title>
		<author>
			<persName><forename type="first">P</forename><surname>Fratta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page">845</biblScope>
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Mutant ubiquitin UBBþ1 is accumulated in sporadic inclusion-body myositis muscle fibers</title>
		<author>
			<persName><forename type="first">P</forename><surname>Fratta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Van Leeuwen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Hol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Vattemi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="1114" to="1117" />
			<date type="published" when="2004">2004a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Proteasome abnormalities participate in the pathogenesis of sporadic inclusion body myositis (s-IBM)</title>
		<author>
			<persName><forename type="first">P</forename><surname>Fratta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page">168</biblScope>
			<date type="published" when="2004">2004b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Proteosome inhibition and aggresome formation in sporadic inclusion-body myositis and in AbPP-overexpressing cultured human muscle fibers</title>
		<author>
			<persName><forename type="first">P</forename><surname>Fratta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcferrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Kja</forename><surname>Davies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note>in press</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Amyloid-beta deposition in skeletal muscle of transgenic mice: Possible model of inclusion body myopathy</title>
		<author>
			<persName><forename type="first">K</forename><surname>Fukuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Pham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Lindsey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">153</biblScope>
			<biblScope unit="page" from="1687" to="1693" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Hassles with taking out the garbage: aggravating aggresomes</title>
		<author>
			<persName><forename type="first">R</forename><surname>Garcia-Mata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y-S</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sztul</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Traffic</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="388" to="396" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Inflammatory muscle diseases</title>
		<author>
			<persName><forename type="first">Hilton-Jones D</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Neurol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="591" to="596" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">ASP1 (BACE2) cleaves the amyloid precursor protein at the beta-secretase site</title>
		<author>
			<persName><forename type="first">I</forename><surname>Hussain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Powell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Howlett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Chapman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Gilmour</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Murdock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Tew</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Meek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Chapman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Schneider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Ratcliffe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Tattersall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">T</forename><surname>Testa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Southan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Ryan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Simmons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">S</forename><surname>Walsh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Dingwall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G ;</forename><surname>Christie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wilczynska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Wilczynski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">K</forename><surname>Strickland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Weisgraber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Cell Neurosci</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="438" to="445" />
			<date type="published" when="2000">2000. 2002</date>
		</imprint>
	</monogr>
	<note>Neurology</note>
</biblStruct>

<biblStruct xml:id="b29">
	<monogr>
		<title level="m" type="main">Transgenic mice over-expressing the C-99 fragment Pathol</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">W</forename><surname>Jin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Hearn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Ogburn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Dang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Nochlin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Ladiges</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Martin</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1998">1998</date>
			<biblScope unit="volume">153</biblScope>
			<biblScope unit="page" from="1679" to="1686" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Aggresomes: a cellular response to misfolded proteins</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Johnston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Ward</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Kopito</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cell Biol</title>
		<imprint>
			<biblScope unit="volume">143</biblScope>
			<biblScope unit="page" from="1883" to="1898" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Orchestrating the unfolded protein response in health and disease</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Kaufman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="page" from="1389" to="1398" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Abnormal accumulation of caveolin-1 and its colocalization with cholesterol, amyloid-b and phosphorylated tau in inclusion-body myositis (IBM) muscle</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kefi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Vattemi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V ;</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Keller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">B</forename><surname>Hanni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Markesbery</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurochem</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="436" to="439" />
			<date type="published" when="2000">2002. 2000</date>
		</imprint>
	</monogr>
	<note>Neurology</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">ADDLs and protofibrils: the missing links?</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">L</forename><surname>Klein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurobiol Aging</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="231" to="233" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Recognition of tau epitopes by anti-neurofilament antibodies that bind to Alzheimer neurofibrillary tangles</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Kopito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ksiezak-Reding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Dickson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Davies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S-H</forename><surname>Yen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="504" to="510" />
			<date type="published" when="1987">2000. Ron D. 2000. 1987. 2001</date>
			<publisher>Kopito RR</publisher>
		</imprint>
	</monogr>
	<note>Trends Biochem Sci</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer-disease patients</title>
		<author>
			<persName><forename type="first">E</forename><surname>Levy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sastre</surname></persName>
		</author>
		<author>
			<persName><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gallo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Piccardo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Ghetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Tagliavini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neuropathol Exp Neurol</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="94" to="104" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">The role of disulfide bridge in the folding and stability of the recombinant human prion protein</title>
		<author>
			<persName><forename type="first">K</forename><surname>Lindsten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Fms</forename><surname>De Vrij</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Verhoef</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Van Leeuwen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Hol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Masucci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Np ;</forename><surname>Dantuma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">R</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Surewicz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">157</biblScope>
			<biblScope unit="page" from="2427" to="2431" />
			<date type="published" when="2001">2002. 2001</date>
		</imprint>
	</monogr>
	<note>Biol</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Inflammatory myopathies: clinical, diagnostic and therapeutic aspects</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">L</forename><surname>Mastaglia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Garlepp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Phillips</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Zilko</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Muscle Nerve</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="407" to="425" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Impaired innervation of cultured human muscle overexpressing bAPP experimentally and genetically: relevance to inclusion-body myopathies</title>
		<author>
			<persName><forename type="first">J</forename><surname>Mcferrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroreport</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="3201" to="3205" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Cultured muscle fibers from Iranian Jewish patients with quadriceps-sparing autosomal-recessive inclusion-body myopathy (AR1-IBM) express features of IBM phenotype</title>
		<author>
			<persName><forename type="first">J</forename><surname>Mcferrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Leclerc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Mcnaught</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Belizaire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Isacson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Jenner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Olanow</surname></persName>
		</author>
		<idno type="DOI">10.1002/jemt.20186by</idno>
		<idno>05/03/2023</idno>
		<ptr target="https://onlinelibrary.wiley.com/terms-and-conditions" />
	</analytic>
	<monogr>
		<title level="m">See the Terms and Conditions</title>
				<imprint>
			<date type="published" when="2000">2005. 2000. 2002. 2003</date>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="38" to="46" />
		</imprint>
		<respStmt>
			<orgName>University Of Illinois At Urbana Champaign, Wiley Online Library</orgName>
		</respStmt>
	</monogr>
	<note>Neurology</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Amyloid filaments in inclusion body myositis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Mendell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Sahenk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Gales</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Paul</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Neurol</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="1229" to="1234" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathies</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mirabella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bilak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neuropathol Exp Neurol</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="774" to="786" />
			<date type="published" when="1996">1996a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Apolipoprotein E and apolipoprotein E messenger RNA in muscle of inclusion-body myositis and myopathies</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mirabella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Weisgraber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="864" to="872" />
			<date type="published" when="1996">1996b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Tripartite management of unfolded proteins in the endoplasmic reticulum</title>
		<author>
			<persName><forename type="first">K</forename><surname>Mori</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">101</biblScope>
			<biblScope unit="page" from="451" to="454" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Ubiquitin immunostaining and inclusion body myositis: Study of 30 patients with inclusion body myositis</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Prayson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Cohen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Pathol</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="887" to="892" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Alvarez RB. 1993. b-Amyloid precursor protein mRNA is increased in inclusion-body myositis muscle</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">N</forename><surname>Rosenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sarkozi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroreport</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="815" to="818" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
	<note>Neurology</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Protein surveillance machinery in brains with spinocerebellar ataxia type 3: redistribution and differential recruitment of 26S proteasome subunits and chaperones to neuronal intranucelar inclusions</title>
		<author>
			<persName><forename type="first">T</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Lindenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Krebs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Scheols</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Laccone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Herms</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rechsteiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Riess</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">B</forename><surname>Landwehrmeyer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="302" to="310" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Protein aggregation and the ubiquitin proteasome pathway: gaining the UPPer hand on neurodegeneration</title>
		<author>
			<persName><forename type="first">Shoesmith</forename><surname>Berke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Paulson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">L</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Genet Dev</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="253" to="261" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Purification and cloning of amyloid precursor protein beta-secretase from human brain</title>
		<author>
			<persName><forename type="first">S</forename><surname>Sinha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Barbour</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Basi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Caccavello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Doan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">F</forename><surname>Dovey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Frigon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Jacobson-Croak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Jewett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Keim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Knops</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Lieberburg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Power</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Tatsuno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Schenk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Seubert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Suomensaari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>John</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">402</biblScope>
			<biblScope unit="page" from="537" to="540" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">g-Secretase Notch, Ab, and Alzheimer&apos;s disease: where do the presenilins fit in?</title>
		<author>
			<persName><forename type="first">S</forename><surname>Sisodia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">St</forename><surname>George-Hyslop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="281" to="290" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">A direct role for protein kinase c and the transcription factor Jun/ AP-1 in the regulation of the Alzheimer&apos;s b-amyloid precursor protein gene</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Terry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Trejo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Massamiri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Deng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">N</forename><surname>Dewji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bayney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Brown</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neuropathol Exp Neurol</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="21682" to="21690" />
			<date type="published" when="1994">1996. 1994</date>
		</imprint>
	</monogr>
	<note>J Biol Chem</note>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Frameshift mutants of b-amyloid precursor protein and ubiquitin-b in Alzheimer&apos;s and Down patients</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Van Leeuwen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>De Kleijn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Van Den Hurk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Neubauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Sonnemans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Sluijs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Koycu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Ramdjielal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Salehi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Marten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">G</forename><surname>Grosveld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Peter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Burbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Hol</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">279</biblScope>
			<biblScope unit="page" from="242" to="247" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Molecular misreading: a new type of transcript mutation expressed during aging</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Van Leeuwen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kamel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Sluijs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Sonnemans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Benne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Swaab</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Salehi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Hol</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurobiol Aging</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="879" to="891" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Presence of BACE1 and BACE2 in muscle fibres of patients with sporadic inclusion-body myositis</title>
		<author>
			<persName><forename type="first">G</forename><surname>Vattemi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcferrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Buxbaum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Pastorino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">358</biblScope>
			<biblScope unit="page" from="1962" to="1964" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Askanas V. 2003b. BACE1 and BACE2 in pathologic and normal human muscle</title>
		<author>
			<persName><forename type="first">G</forename><surname>Vattemi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcferrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Pastorino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Buxbaum</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Exp Neurol</title>
		<imprint>
			<biblScope unit="volume">179</biblScope>
			<biblScope unit="page" from="150" to="158" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Cystatin C colocalizes with amyloid-b and co-immunoprecipitates with amyloid-b precursor protein in sporadic inclusion-body myositis muscle</title>
		<author>
			<persName><forename type="first">G</forename><surname>Vattemi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kefi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Vattemi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcferrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurochem</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="1539" to="1546" />
			<date type="published" when="2003">2003b. 2003c</date>
		</imprint>
	</monogr>
	<note>Neurology</note>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Endoplasmic reticulum stress and unfolded protein response in inclusion body myositis muscle</title>
		<author>
			<persName><forename type="first">G</forename><surname>Vattemi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcferrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">164</biblScope>
			<biblScope unit="page" from="1" to="7" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">The 26S proteasome: a molecular machine designed for controlled proteolysis</title>
		<author>
			<persName><forename type="first">D</forename><surname>Voges</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Zwickl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Baumeister</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Wigley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Fabunmi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Marino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Muallem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">N</forename><surname>Demartino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Thomas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annu Rev Biochem</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="481" to="490" />
			<date type="published" when="1999">1999. 1999</date>
		</imprint>
	</monogr>
	<note>J Cell Biol</note>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Novel cytoplasmic immunolocalization of RNA-polymerase-II in inclusion-body myositis muscle</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Wilczynski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Wilczynski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroreport</title>
		<imprint>
			<biblScope unit="volume">156</biblScope>
			<biblScope unit="page" from="1809" to="1814" />
			<date type="published" when="2000">2000Pathol. 2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Increase of nitric oxide synthases and nitrotyrosine in inclusion-body myositis</title>
		<author>
			<persName><forename type="first">Yang</forename><surname>Ch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">-C</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroreport</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="153" to="158" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Immunolocalization of transcription factor NF-KB in inclusion-body myositis muscle and at normal human neuromuscular junctions</title>
		<author>
			<persName><forename type="first">C-C</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosci Lett</title>
		<imprint>
			<biblScope unit="volume">254</biblScope>
			<biblScope unit="page" from="77" to="80" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
